Nephros Inc (NEPH)
2.20
0.00 (0.00%)
USD |
NASDAQ |
May 06, 16:00
Nephros Free Cash Flow: 0.827M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | 0.827M |
September 30, 2023 | 0.869M |
June 30, 2023 | 0.137M |
March 31, 2023 | -1.161M |
December 31, 2022 | -3.371M |
September 30, 2022 | -3.511M |
June 30, 2022 | -4.264M |
March 31, 2022 | -3.206M |
December 31, 2021 | -1.453M |
September 30, 2021 | -2.644M |
June 30, 2021 | -3.551M |
March 31, 2021 | -5.38M |
December 31, 2020 | -7.142M |
September 30, 2020 | -5.252M |
June 30, 2020 | -4.05M |
March 31, 2020 | -3.433M |
December 31, 2019 | -2.29M |
September 30, 2019 | -3.182M |
June 30, 2019 | -3.676M |
March 31, 2019 | -3.69M |
December 31, 2018 | -3.662M |
September 30, 2018 | -1.34M |
June 30, 2018 | -0.931M |
March 31, 2018 | -0.087M |
December 31, 2017 | -0.077M |
Date | Value |
---|---|
September 30, 2017 | -2.399M |
June 30, 2017 | -2.481M |
March 31, 2017 | -2.268M |
December 31, 2016 | -2.157M |
September 30, 2016 | -2.869M |
June 30, 2016 | -3.198M |
March 31, 2016 | -3.446M |
December 31, 2015 | -3.815M |
September 30, 2015 | -3.406M |
June 30, 2015 | -3.079M |
March 31, 2015 | -2.79M |
December 31, 2014 | -2.495M |
September 30, 2014 | -2.551M |
June 30, 2014 | -1.892M |
March 31, 2014 | -3.276M |
December 31, 2013 | -3.583M |
September 30, 2013 | -3.155M |
June 30, 2013 | -3.734M |
March 31, 2013 | -3.568M |
December 31, 2012 | -2.214M |
September 30, 2012 | -2.372M |
June 30, 2012 | -1.246M |
March 31, 2012 | -0.323M |
December 31, 2011 | -1.296M |
September 30, 2011 | -1.33M |
Free Cash Flow Range, Past 5 Years
-7.142M
Minimum
Dec 2020
0.869M
Maximum
Sep 2023
-2.933M
Average
-3.371M
Median
Dec 2022
Free Cash Flow Benchmarks
Perspective Therapeutics Inc | -37.98M |
Retractable Technologies Inc | 1.914M |
Xtant Medical Holdings Inc | -10.97M |
Asensus Surgical Inc | -64.19M |
Catheter Precision Inc | -20.70M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -0.237M |
Cash from Investing (Quarterly) | -0.075M |
Cash from Financing (Quarterly) | -0.003M |
Free Cash Flow Per Share (Quarterly) | -0.0226 |
Free Cash Flow to Equity (Quarterly) | -0.237M |
Free Cash Flow Yield | 3.62% |